Libertyville, IL, United States of America

Zhonghua Pei

This inventor holds 33 USPTO granted patents and 19 published patent applications, plus 3 CIPO patents and 11 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: Abbott Laboratories Corporation, Genentech, Inc., Ideaya Biosciences, Inc.. Active years: 2000-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zhonghua Pei. Retrieved from https://idiyas.com/inventor/zhonghua-pei

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 33 (Patent Applications = 19)

% Patents Active = 57.6

CIPO Patents = 3 (Patent Applications = 12)

EPO Patents = 11 (Patent Applications = 21)

Average Co-Inventor Count = 7.2

ph-index = 6

Forward Citations = 189(Granted Patents)

Location History:

Libertyville, IL (US) (2000 - 2014)
Burlingame, CA (US) (2012 - 2014)
South San Francisco, CA (US) (2020 - 2023)

Company Filing History:

15 out of 4,188

Abbott Laboratories Corporation

Ideaya Biosciences, Inc.

Newlink Genetics Corporation

patents

6. 1 out of 1

Ideaya Bioscience, Inc.

patent

where one patent can have more than one assignee

Years Active: 2000-2026

Loading Chart...

Areas of Expertise:

TDO2 Inhibitors

Dipeptidyl Peptidase-IV

Protein Tyrosine Phosphatase

Thiadiazolyl Derivatives

2-Oxoquinazoline Derivatives

Pyrrolobenzodiazepine Prodrugs

Cell Adhesion Compounds

Vitamin D Receptor Activators

Amino(oxo) Acetic Acid

Hindered Disulfide Drug Conjugates

DAG O-Acyltransferase Inhibitors

N-7 Substituted Purine

33 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12583858 - TDO2 inhibitors (2026-03-24),

2. 12509454 - Thiadiazolyl derivatives (2025-12-30),

3. 12503467 - 2-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitors (2025-12-23),

4. 11827639 - TDO2 and IDO1 inhibitors (2023-11-28),

5. 11603373 - TDO2 and IDO1 inhibitors (2023-03-14),

6. 11576979 - Pyrrolobenzodiazepine prodrugs and antibody conjugates thereof (2023-02-14),

7. 11130759 - 2-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitors (2021-09-28),

8. 11084798 - 2-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitors (2021-08-10),

9. 11046691 - 2-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitors (2021-06-29),

10. 10800780 - TDO2 Inhibitors (2020-10-13),

11. 10729738 - Hindered disulfide drug conjugates (2020-08-04),

12. 10532108 - Pyrrolobenzodiazepine prodrugs and antibody conjugates thereof (2020-01-14),

13. 8828990 - N-7 substituted purine and pyrazolopyrimine compounds, compositions and methods of use (2014-09-09),

14. 8637546 - Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DDP-IV) (2014-01-28),

15. 8586594 - Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme (2013-11-19),

Title: The Innovative Journey of Zhonghua Pei

Introduction: Zhonghua Pei, a talented inventor based in Libertyville, IL (US), has made significant contributions to the field of technology with his groundbreaking inventions and patents.

Latest Patents: Zhonghua Pei holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his diverse range of expertise and innovative thinking.

Career Highlights: With a background in engineering and a passion for problem-solving, Zhonghua Pei has had a successful career marked by his ability to turn creative ideas into tangible solutions. He has worked for leading tech companies, where he has spearheaded projects that have pushed the boundaries of innovation.

Collaborations: Throughout his career, Zhonghua Pei has collaborated with top researchers, engineers, and scientists to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of many projects.

Conclusion: Zhonghua Pei's relentless pursuit of innovation and his dedication to creating impactful technologies have solidified his reputation as a visionary inventor in the industry. His work continues to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.